Close mobile menu×
Close mobile menu

David J. Lederer, MD

Board Certifications: 
Pulmonary Disease Medicine, Internal Medicine, Critical Care Medicine
Accepting New Patients
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 
(212) 305-8203

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

America's Top Doctor
NY Top Doctor

Board Certifications

  • Pulmonary Disease Medicine
  • Internal Medicine
  • Critical Care Medicine

Clinical Expertise

  • Pulmonary Fibrosis
  • Interstitial Pulmonary Fibrosis
  • Chronic Lung Disease
  • Interstitial Lung Disease
  • Idiopathic Pulmonary Fibrosis

Education & Training

  • State University of New York - Downstate Health Sciences Center
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

About David Lederer

David J. Lederer, MD, MS is the Co-Director of the New York Presbyterian/Columbia University Interstitial Lung Disease Program and Pulmonary Director of the Pulmonary & Intensive Care Translational Outcomes (PICTOR) Group at Columbia University. He is the principal investigator of two NHLBI-funded studies: the MESA Lung Fibrosis Study and the Lung Transplant Body Composition Study. He is the editor-in-chief of the Annals of the American Thoracic Society and sits on the editorial board of the American Journal of Respiratory and Critical Care Medicine. Dr. Lederer is a Senior Medical Advisor for the Pulmonary Fibrosis Foundation and a standing member of the IRAP study section at the Center for Scientific Review at the NIH and the NHLBI K23 study section. 

Academic Titles

  • Associate Professor of Medicine and Epidemiology (in Pediatrics)

Administrative Positions

  • Co-Director, Interstitial Lung Disease Program
  • Pulmonary Director, Pulmonary & Intensive Care Translational Outcomes Research (PICTOR) Group
  • Senior Medical Advisor, Pulmonary Fibrosis Foundation

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Male

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
161 Fort Washington Avenue
Room 321A
New York, New York 10032
Phone:
(212) 305-8203
Fax:
(212) 305-8426
Primary

Research

Dr. Lederer is the principal investigator of the MESA ILD Study and the Columbia IPF Study, studies funded by the National Heart, Lung, and Blood Institute and the Robert Wood Johnson Foundation. His research focuses on the causes of human lung fibrosis (including idiopathic pulmonary fibrosis, subclinical interstitial lung disease, and lung transplant-associated bronchiolitis obliterans) and outcomes after lung transplantation.

Research Interests

  • Disparities in access to subspecialty pulmonary services and lung transplantation
  • Body composition and lung transplantation
  • Subclinical interstitial lung disease
  • Obstructive sleep apnea and alveolar injury

Grants

R01 HL137234 (Lederer)                                                           01/15/2018 – 12/31/2021
NIH/NHLBI                                                                                                                 
Obstructive Sleep Apnea and Subclinical Lung Injury in Health and Disease
The Aims of this project are to determine whether OSA causes subclinical alveolar epithelial cell injury in adults with and without pulmonary fibrosis
Role: PI

R01 HL103676 (Lederer)                                                           04/15/2011 – 04/14/2021
NIH/NHLBI                                                                                                                 
Subclinical Interstitial Lung Disease in MESA and FAR-ILD   
The Aims of this project are to validate high attenuation areas (HAA) on CT as a marker of subclinical interstitial lung disease and perform genome wide association and linkage studies of HAA.
Role: PI

R01 HL103676-S1 (Lederer)                                                     09/05/2017 – 04/30/2020
NIH/NHLBI                                                                                                                 
Administrative Supplement: Subclinical Interstitial Lung Disease in MESA and FAR-ILD
This Diversity Supplement supports training of Imaani Easthausen, an underrepresented minority, during her Master’s degree training in Biostatistics at the Mailman School of Public Health
Role: PI (Trainee: Easthausen)

K24 HL131937 (Lederer)         09/01/2016 – 08/31/2021
NIH/NHLBI                                                                                                                                        
Mentored Patient Oriented Research in Pulmonary Fibrosis and Lung Transplantation
The Aim of this project is to mentor post-doctoral trainees and faculty in patient-oriented research in pulmonary fibrosis and lung transplantation
Role: PI

THE FAMILIES AT RISK FOR INTERSTITIAL LUNG DISEASE STUDY (FAR-ILD) (P&S Industry Clinical Trial)

Jun 14 2018 - Jun 14 2023

MODELING, PATHOGENESIS AND TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS (Federal Gov)

Sep 20 2016 - May 31 2023

FRAILTY IN LUNG TRANSPLANTATION. PLEASE NOTE THAT THE TITLE IS A WORKING TITLE SO THE PI S MAY UPDATE (Federal Gov)

Jul 1 2017 - Jun 30 2022

OBSTRUCTIVE SLEEP APNEA AND SUBCLINICAL LUNG INJURY IN HEALTH AND DISEASE (Federal Gov)

Jan 15 2018 - Dec 31 2021

MENTORED PATIENT ORIENTED RESEARCH IN PULMONARY FIBROSIS AND LUNG TRANSPLANTATION (Federal Gov)

Sep 1 2016 - Jul 31 2021

SUBCLINICAL INTERSTITIAL LUNG DISEASE IN MESA AND FAR-ILD (Federal Gov)

May 1 2017 - Apr 30 2021

GENOMIC AND TRANSCRIPTOMIC ANALYSIS OF EMPHYSEMA AND SUBCLINICAL LLD (Federal Gov)

May 15 2016 - Apr 30 2021

OBSERVATION REGISTRY FOR INTERSTITIAL LUNG DISEASES: PFF PATIENT REGISTRY (Private)

Apr 18 2016 - Oct 31 2020

IDIOPATHIC PULMONARY FIBROSIS PROSPECTIVE OUTCOMES (IPF- PRO) REGISTRY (P&S Industry Clinical Trial)

Apr 2 2015 - Apr 2 2020

TRANSPLANT OPTIMIZATION USING FUNCTIONAL IMAGING (P&S Industry Clinical Trial)

Mar 18 2015 - Mar 18 2020

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RIOCIGUAT (0.5 MG, 1.0 MG, 1.5 MG, 2.0 MG AND 2.5 MG TID) IN PATIENTS WITH SYMPTOMATIC PULMONARY HYPERTENSION ASSOCIATED WITH IDIOPATHIC (P&S Industry Clinical Trial)

Nov 10 2014 - Nov 10 2019

RLDC: MOLECULAR PATHWAY-DRIVEN DIAGNOSTICS & THERAPEUTICS FOR RARE LUNG DISEASES (Federal Gov)

Sep 18 2014 - Jul 31 2019

STUDY OF CLINICAL EFFICACY OF ANTIMICROBIAL THERAPY STRATEGY USING PRAGMATIC DESIGN IN IDIOPATHICPULMONARY FIBROSIS (Federal Gov)

Aug 1 2017 - Jul 31 2018

A.PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF GS-6624 IN SUBJECTS WITH IDIOPATHIC PULMONARY FIBROSIS (RAINIER) (P&S Industry Clinical Trial)

Apr 26 2013 - Apr 26 2018

OBESITY, INFLAMMATION AND LUNG INJURY AFTER LUNG TRANSPLANTATION (Federal Gov)

May 23 2013 - Mar 31 2018

AN OPEN-LABEL EXTENSION TRIAL FOR THE LONG TERM SAFETY OF ORAL BIBF 1120 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) (P&S Industry Clinical Trial)

Feb 4 2013 - Feb 4 2018

AN OPEN-LABEL EXTENSION TRIAL OF THE LONG TERM SAFETY OF ORAL BIBF 1120 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) (P&S Industry Clinical Trial)

Feb 4 2013 - Feb 4 2018

A PHASE 2, RANDOMIZED DOSE-RANGING STUDY TO EVALUATE THE EFFICACY OF TRALOKINUMAB IN ADULTS WITH IDIOPATHIC PULMONARY FIBROSIS - CAT-354-1066 - AAAK5259 (P&S Industry Clinical Trial)

Jan 30 2013 - Jan 30 2018

A PHASE 2, RANDOMIZED DOSE-RANGING STUDY TO EVALUATE THE EFFICACY OF TRALOKINUMAB IN ADULTS WITH IDIOPATHIC PULMONARY FIBROSIS (P&S Industry Clinical Trial)

Jan 30 2013 - Jan 30 2018

CLINICAL RISK FACTORS FOR PRIMARY GRAFT DYSFUNCTION (Federal Gov)

Aug 1 2014 - Jun 30 2017

BIBF1120 (P&S Industry Clinical Trial)

Oct 10 2011 - Oct 10 2016

RLDC MOLECULAR PATHWAY-DRIVEN DIAGNOSTIC AND THERAPEUTICS FOR RARE LUNG DISEASES (Federal Gov)

Sep 18 2014 - Jul 31 2016

FOXP3+ TREG CELLS AND PRIMARY GRAFT DYSFUNCTION IN CLINICAL LUNG TRANSPLANT RECIPIENTS (Federal Gov)

May 15 2012 - Apr 30 2016

ARTEMIS PH: A PHASE3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL-GROUP STUDY TO EVALUATE (P&S Industry Clinical Trial)

Dec 23 2009 - Dec 23 2014

PHASE II STUDY OF INHALES CARBON MONOXIDE FOR THE TREATMENT OF IPF (Federal Gov)

Mar 1 2012 - Jun 30 2014

ARTEMIS (P&S Industry Clinical Trial)

Jan 29 2009 - Jul 30 2013

SUBCLINICAL INTERSTITIAL LUNG DISEASE IN MESA: THE MESA LUNG FIBROSIS STUDY (Private)

May 1 2012 - Apr 30 2013

EXPLAINING RACIAL AND ETHNIC DISPARITIES IN IDIOPATHIC PULMONARY FIBROSIS (Federal Gov)

Apr 1 2008 - Mar 31 2013

GENCTICS OF PRIMARY GRAFT DYSFUNCTION (Federal Gov)

Feb 15 2007 - Jan 31 2013

CLINICAL RISK FACTORS FOR PRIMARY GRAFT DYSFUNCTION (Federal Gov)

Aug 15 2007 - Jul 31 2012

EXPLAINING RACIAL AND ETHNIC DISPARITIES IN IDIOPATHIC PULMO NARY FIBROSIS (Private)

Jul 1 2008 - Jun 30 2011

Selected Publications

Original, Peer-reviewed articles

  1. * Singer JP, Diamond JM, Anderson MR, Katz PP, Covinsky K, Oyster M, Blue T, Soong A, Kalman L, Shrestha P, Arcasoy SM, Greenland JR, Shah L, Kukreja J, Blumenthal NP, Easthausen I, Golden JA, McBurnie A, Cantu E, Sonett J, Hays S, Robbins H, Raza K, Bacchetta M, Shah RJ, D'Ovidio F, Venado A, Christie JD, Lederer DJ. Frailty phenotypes and mortality after lung transplantation: a prospective cohort study. Am J Transplant 2018 in press. Doi: 10.1111/ajt.14873.  PMID: 29667786
  2. * Bernstein EJ, Bathon JM, Lederer DJ. Survival of adults with systemic autoimmune rheumatic diseases and pulmonary arterial hypertension after lung transplantation. Rheumatology (Oxford). 2018 in press doi: 10.1093/rheumatology/kex527. PMID: 29447389
  3. * Bernstein EJ, Khanna D, Lederer DJ.Screening High Resolution Computed Tomography of the Chest to Detect Interstitial Lung Disease in Systemic Sclerosis: A Global Survey of Rheumatologists. Arthritis Rheumatol. 2018 in press. doi: 10.1002/art.40441. PMID: 29426066
  4. Shaver CM, Wickersham N, McNeil JB, Nagata H, Miller A, Landstreet SR, Kuck JL, Diamond JM, Lederer DJ, Kawut SM, Palmer SM, Wille KM, Weinacker A, Lama VN, Crespo MM, Orens JB, Shah PD, Hage CA, Cantu E 3rd, Porteous MK, Dhillon G, McDyer J, Bastarache JA, Christie JD, Ware LB; Lung Transplant Outcomes Group (LTOG). Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injury. JCI Insight. 2018 in press PMID: 29367464  PMCID PMC5821179   
  5. Gannon WD, Lederer DJ, Biscotti M, Javaid A, Patel NM, Brodie D, Bacchetta M, Baldwin MR. Outcomes and Mortality Prediction Model of Critically Ill Adults With Acute Respiratory Failure and Interstitial Lung Disease. Chest. 2018 in press. doi: 10.1016/j.chest.2018.01.006. PMID:  29353024
  6. * Cosgrove GP, Bianchi P, Danese S, Lederer DJ. Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey. BMC Pulm Med. 2018 Jan 17;18(1):9. doi: 10.1186/s12890-017-0560-x. PMID: 29343236  PMCID: PMC5773175
  7. Cantu E, Diamond JM, Suzuki Y, Lasky J, Schaufler C, Lim B, Shah R, Porteous M, Lederer DJ, Kawut SM, Palmer SM, Snyder LD, Hartwig MG, Lama VN, Bhorade S, Bermudez C, Crespo M, McDyer J, Wille K, Orens J, Shah PD, Weinacker A, Weill D, Wilkes D, Roe D, Hage C, Ware LB, Bellamy SL, Christie JD; Lung Transplant Outcomes Group. Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant. ¨. 2018 Jan 15;197(2):235-243. doi: 10.1164/rccm.201706-1140OC. PMID: 28872353
  8. * Sack C, Vedal S, Sheppard L, Raghu G, Barr RG, Podolanczuk A, Doney B, Hoffman EA, Gassett A, Hinckley-Stukovsky K, Williams K, Kawut S, **Lederer DJ, **Kaufman JD. Air pollution and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA) air-lung study. Eur Resp J 2017;50(6):  pii: 1700559. doi: 10.1183/13993003.00559-2017. PMID: 29217611
    **Co-senior authors
  9. * Layton AM, Armstrong HF, Baldwin MR, Podolanczuk AJ, Pieszchata NM, Singer JP, Arcasoy SM, Meza KS, D'Ovidio F, Lederer DJ. Frailty and maximal exercise capacity in adult lung transplant candidates. Respir Med. 2017;131:70-76. PMID: 28947046  PMCID pending
  10. * Maldonado DA, RoyChoudhury A, Lederer DJ. A Novel Patient-Centered “Intention-to-treat” Metric of U.S. Lung Transplant Center Performance. Am J Transplant 2017; 18(1):226-23. PMID: 28862792. PMCID: PMC5739968  doi: 10.1111/ajt.14486.
  11. * Sack CS, Doney BC, Podolanczuk AJ, Hooper LG, Seixas NS, Hoffman EA, Kawut SM, Vedal S, Raghu G, Barr RG, **Lederer DJ, **Kaufman JD. Occupational Exposures and Subclinical Interstitial Lung Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Air- Lung Study. Am J Respir Crit Care Med. 2017;196(8):1031-1039. doi: 10.1164/rccm.201612-2431OC. PMID: 28753039 PMC Journal – PMCID in process.
    **Co-senior authors
  12. * Kim JS, Podolanczuk AJ, Borker P, Kawut SM, Raghu G, Kaufman JD, Hinckley Stukovsky KD, Hoffman EA, Barr RG, Gottlieb DJ, Redline SS, Lederer DJ. Obstructive Sleep Apnea and Subclinical Interstitial Lung Disease in MESA. Ann Am Thorac Soc. 2017;14(12):1786-1795. PMID 28613935 PMC Journal – PMCID in process. doi: 10.1513/AnnalsATS.201701-091OC.
  13. * Podolanczuk AJ, Oelsner EC, Barr RG, Bernstein EJ, Hoffman EA, Easthausen IJ, Hinckley Stukovsky K, RoyChoudhury A, Michos ED, Raghu G, Kawut SM, Lederer DJ. High attenuation areas on chest CT and clinical respiratory outcomes in community-dwelling adults. Am J Resp Crit Care Med 2017;196(11):1434-1442. doi: 10.1164/rccm.201703-0555OC. PMID: 28613921
  14. * Armstrong HF, Podolanczuk AJ, Barr RG, Oelsner EC, Kawut SM, Hoffman EA, Tracy R, Kaminski N, McClelland RL, Lederer DJ. Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-dwelling Adults: The Multi-Ethnic Study of Atherosclerosis. Am J Respir Crit Care 2017; 196(10):1311-1317. PMID: 28570100 PMC Journal – PMCID in Process. DOI: 10.1164/rccm.201701-0254OC.
  15. * Restivo M, Podolanczuk A, Kawut S, Raghu G, Leary P, Barr RG, Lederer DJ. Antacid use and subclinical interstitial lung disease: the MESA Study. Eur Resp J 2017; in press. PMID: 28526800
  16. * Manichaikul A, Wang XQ, Sun L, Dupuis J, Borczuk AC, Nguyen JN, Raghu G, Hoffman EA, Onengut-Gumuscu S, Farber EA, Kaufman JD, Rabinowitz D, Stukovsky KDH, Kawut SM, Hunninghake GM, Washko GR, O'Connor GT, Rich SS, Barr RG, Lederer DJ. Genome-wide association study of subclinical interstitial lung disease in MESA. Respir Res. 2017;18;18(1):9  PMID:28521775 PMCID:PMC5437638 DOI:10.1186/s12931-017-0581-2
  17. * Baldwin MR, Singer JP, Huang D, Sell J, Gonzalez WC, Pollack L, Maurer MS, D'Ovidio FF, Bacchetta M, Sonett JR, Arcasoy SM, Shah L, Robbins H, Hays SR, Kukreja J, Greenland JR, Shah RJ, Leard L, Morrell M, Gries C, Katz PP, Christie JD, Diamond JM, Lederer DJ. Refining Low Physical Activity Measurement Improves Frailty Assessment in Advanced Lung Disease and Survivors of Critical Illness. Ann Am Thorac Soc. 2017; 14(8):1270-1279. doi: 10.1513/AnnalsATS.201612-1008OC. PMID: 28398076  PMC Journal – PMCID In Process.
  18. * Baldwin MR, Sell JL, Heyden N, Javaid A, Berlin DA, Gonzalez WC, Bach PB, Maurer MS, Lovasi GS, Lederer DJ. Race, Ethnicity, Health Insurance, and Mortality in Older Survivors of Critical Illness. Crit Care Med. 2017; 45(6):e583-e591 doi: 10.1097/CCM.0000000000002313. PMID: 28333761 PMCID: PMC5433910
  19. Rosas IO, Goldberg HJ, Collard HR, El-Chemaly S, Flaherty K, Hunninghake GM, Lasky JA, Lederer DJ, Machado R, Martinez FJ, Maurer R, Teller D, Noth I, Peters E, Raghu G, Garcia JGN, Choi AMK. A Phase II Clinical Trial of Low Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis. Chest (in press). PMID: 29100885 PMCID in process
  20. Oelsner EC, Smith BM, Hoffman EA, Folsom AR, Kawut SM, Kaufman JD, Manichaikul A, Lederer DJ, Schwartz JE, Watson KE, Enright PL, Austin JHM, Lima JAC, Shea SJ, Barr RG. Associations between emphysema-like lung on CT and incident airflow limitation: a general population-based cohort study. Thorax. 2017 (in press) PMID: 29074811 PMCID in process
  21. Cantu E, Diamond JM, Suzuki Y, Lasky J, Schaufler C, Lim B, Shah R, Porteous M, Lederer DJ, Kawut SM, Palmer SM, Snyder LD, Hartwig MG, Lama VN, Bhorade S, Bermudez C, Crespo M, McDyer J, Wille K, Orens J, Shah PD, Weinacker A, Weill D, Wilkes D, Roe D, Hage C, Ware LB, Bellamy SL, Christie JD; Lung Transplant Outcomes Group. Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction After Lung Transplant. Am J Respir Crit Care Med (in press) PMID: 28872353  doi: 10.1164/rccm.201706-1140OC
  22. Pollack LR, Goldstein NE, Gonzalez WC, Blinderman CD, Maurer MS, Lederer DJ, Baldwin MR. The Frailty Phenotype and Palliative Care Needs of Older Survivors of Critical Illness. J Am Geriatr Soc 2017. doi: 10.1111/jgs.14799. in press. PMID:28263377 DOI:10.1111/jgs.14799
  23. * Manichaikul A, Sun L, Borczuk AC, Onengut-Gumuscu S, Farber EA, Mathai SK, Zhang W, Raghu G, Kaufman JD, Hinckley-Stukovsky KD, Kawut SM, Jelic S, Liu W, Fingerlin TE, Schwartz DA, Sell JL, Rich SS, Barr RG, Lederer DJ. Plasma Soluble Receptor for Advanced Glycation Endproducts in Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc. 2017 ;14(5):628-635. doi: 10.1513/AnnalsATS.201606-485OC. PMID: 28248552  PMCID: PMC5427736 DOI: 10.1186/s12931-017-0581-2
  24. * Podolanczuk AJ, Raghu G, Tsai MY, Kawut SM, Peterson E, Sonti R, Rabinowitz D, Johnson C, Barr RG, Hinckley Stukovsky K, Hoffman EA, Carr JJ, Ahmed FS, Jacobs DR, Watson K, Shea SJ, Lederer DJ. Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study. Thorax 2017; 48(5):1442-1452. PMID:27471206 PMCID:PMC5089905 DOI:10.1183/13993003.00129-2016
  25. * Tong Y, Udupa JK, Torigian D, Odhner D, Wu C, Pednekar G, Palmer S, Roenshtein A, Shirk MA, Newell JD, Porteous M, Diamond JM, Christie JD, Lederer DJ. Chest Fat Quantification via CT Based on Standardized Anatomy Space in Adult Lung Transplant Candidates. PLoS ONE 2017; 12(1): e0168932. PMID: 28046024 doi:10.1371/journal.pone.0168932  PMCID: PMC5207652
  26. Porteous MK, Lee JC, Lederer DJ, Palmer SM, Cantu E, Shah RJ, Bellamy SL, Lama VN, Bhorade SM, Crespo MM, McDyer JF, Wille KM, Localio AR, Orens JB, Shah PD, Weinacker AB, Arcasoy S, Wilkes DS, Ware LB, Christie JD, Kawut SM, Diamond JM; Lung Transplant Outcomes Group.

Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension. Ann Am Thorac Soc. 2017 Jul 18. doi: 10.1513/AnnalsATS.201610-810OC. [Epub ahead of print] PMID: 28719755 PMC Journal – PMCID in process.

  1. *Podolanczuk AJ, Oelsner EC, Barr RG, Hoffman EA, Armstrong HF, Austin JH, Basner RC, Bartels MN, Christie JD, Enright PL, Gochuico BR, Hinckley Stukovsky K, Kaufman JD, Hrudaya Nath P, Newell JD Jr, Palmer SM, Rabinowitz D, Raghu G, Sell JL, Sieren J, Sonavane SK, Tracy RP, Watts JR, Williams K, Kawut SM, Lederer DJ. High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study. Eur Resp J. 2016; 48(5):1442-52. PubMed PMID: 27471206 PMCID: PMC5089905
  2. Vock DM, Durheim MT, Tsuang WM, Finlen Copeland CA, Tsiatis AA, Davidian M, Neely ML, Lederer DJ, Palmer SM. The Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation. Ann Am Thorac Soc 2016; 14(2):172-181. PMID:27779905 PMCID:PMC5427730 DOI: 10.1513/AnnalsATS.201606-507OC
  3. *Bernstein EJ, Barr RG, Austin JH, Kawut SM, Raghu G, Sell JL, Hoffman EA, Newell JD Jr, Watts JR Jr, Nath PH, Sonavane SK, Bathon JM, Majka DS, Lederer DJ. Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis. Thorax. 2016; 71(12):1082-1090.  PMID: 27609750 PMCID:PMC5342945 DOI:10.1136/thoraxjnl-2016-208932
  4. *Diamond JM, Arcasoy S, McDonnough JA, Sonett JR, Bacchetta M, D'Ovidio F, Cantu E 3rd, Bermudez CA, McBurnie A, Rushefski M, Kalman LH, Oyster M, D'Errico C, Suzuki Y, Giles JT, Ferrante A, Lippel M, Singh G, Lederer DJ**, Christie JD**. Adipose Gene Expression Profile Changes With Lung Allograft Reperfusion. Am J Transplant. 2017;17(1):239-245. PMID: 27421969. PMCID:PMC5195853 DOI:10.1111/ajt.13964 **Co-senior authors
  5. Diamond JM, Cantu E, Porteous M, Suzuki Y, Meyer KC, Lederer D, Milewski RK, Arcasoy S, D'Ovidio F, Bacchetta M, Sonett JR, Singh G, Costa J, Tobias JW, Rodriguez H, Van Deerlin VM, Olthoff KM, Shaked A, Chang BL, Christie JD; Clinical Trials in Organ Transplantation (CTOT)-03 Investigators. Peripheral Blood Gene Expression Changes Associated with Primary Graft Dysfunction after Lung Transplantation. Am J Transplant. In press PMID: 28117940
  6. Raghu G, Brown KK, Collard HR, Cottin V, Gibson KF, Kaner RJ, Lederer DJ, Martinez FJ, Noble PW, Song JW, Wells AU, Whelan TP, Wuyts W, Moreau E, Patterson SD, Smith V, Bayly S, Chien JW, Gong Q, Zhang JJ, O'Riordan TG. Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial. Lancet Respir Med. 2017 Jan;5(1):22-32. PMID: 27939076 doi: 10.1016/S2213-2600(16)30421-0.
  7. Nathan SD, Albera C, Bradford WZ, Costabel U, Glaspole I, Glassberg MK, Kardatzke DR, Daigl M, Kirchgaessler KU, Lancaster LH, Lederer DJ, Pereira CA, Swigris JJ, Valeyre D, Noble PW. Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis. Lancet Resp Med 2017 5(1):33-41. PMID: 27876247
  8. Abbas AA, Diamond JM, Chehoud C, Chang B, Kotzin JJ, Young JC, Imai I, Haas AR, Cantu E, Lederer DJ, Meyer K, Milewski RK, Olthoff KM, Shaked A, Christie JD, Bushman FD, Collman RG. The Perioperative Lung Transplant Virome: Torque Teno Viruses are Elevated in Donor Lungs and Show Divergent Dynamics In Primary Graft Dysfunction. Am J Transplant. 2016; PubMed PMID: 27731934
  9. Armstrong HF, Lederer DJ, Bacchetta M, Bartels MN. Primary graft dysfunction: Long-term physical function outcomes among lung transplant recipients. Heart Lung. 2016; 45(6):544-9. PubMed PMID: 27593492
  10. Slankard M, Michelis MA, Mansukhani M, McGoey B, Paige A, Andrews H, Lederer D, Canfield S, DiMango E. Impact of the Arg 16 allele of the B2AR gene on the effect of withdrawal of LABA in patients with moderate to severe asthma. J Asthma. 2016; 53(8):783-9. PubMed PMID: 27050801
  11. Albera C, Costabel U, Fagan EA, Glassberg MK, Gorina E, Lancaster L, Lederer DJ, Nathan SD, Spirig D, Swigris JJ. Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function. Eur Resp J. 2016; 48(3):843-51. PubMed PMID: 27471208
  12. *Weingarten JA, Dubrovsky B, Basner RC, Redline S, George L, Lederer DJ. Polysomnographic Measurement of Sleep Duration and Bodily Pain Perception in the Sleep Heart Health Study. Sleep. 2016; 39(8):1583-9. PubMed PMID: 27166228, PMCID: PMC4945318
  13. Berning JN, Poor AD, Buckley SM, Patel KR, Lederer DJ, Goldstein NE, Brodie D, Baldwin MR. A Novel Picture Guide to Improve Spiritual Care and Reduce Anxiety in Mechanically Ventilated Adults in the Intensive Care Unit. Ann Am Thorac Soc. 2016; 13(8):1333-42. PubMed PMID: 27097049, PMCID: PMC5021077
  14. Oelsner EC, Carr JJ, Enright PL, Hoffman EA, Folsom AR, Kawut SM, Kronmal RA, Lederer DJ, Lima JA, Lovasi GS, Smith BM, Shea SJ, Barr RG. Per cent emphysema is associated with respiratory and lung cancer mortality in the general population: a cohort study. Thorax. 2016; 71(7):624-32. NIHMSID: NIHMS803748 PubMed PMID: 27048196, PMCID: PMC4960821
  15. Costa J, Sreekanth S, Kossar A, Raza K, Lederer DJ, Robbins H, Shah L, Sonett JR, Arcasoy S, D'Ovidio F. Donor lung assessment using selective pulmonary vein gases. Eur J Cardiothorac Surg. 2016; PubMed PMID: 27242362
  16. Nathan SD, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Glasscock KF, King TE Jr, Lancaster L, Lederer DJ, Lin Z, Pereira CA, Swigris JJ, Valeyre D, Noble PW, Wells AU. Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis. Thorax. 2016; 71(5):429-35. PubMed PMID: 26968970, PMCID: PMC4862066
  17. Diamond JM, Porteous MK, Jackson Roberts L 2nd, Wickersham N, Rushefski M, Kawut SM, Shah RJ, Cantu E 3rd, Lederer DJ, Chatterjee S, Lama VN, Bhorade S, Crespo M, McDyer J, Wille K, Orens J, Weinacker A, Arcasoy S, Shah PD, Wilkes DS, Hage C, Palmer SM, Snyder L, Calfee CS, Ware LB, Christie JD. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia. J Heart Lung Transplant. 2016; 35(4):500-7. NIHMSID: NIHMS750106 PubMed PMID: 26856667, PMCID: PMC4821817
  18. *Sell JL, Bacchetta M, Goldfarb SB, Park H, Heffernan PV, Robbins HA, Shah L, Raza K, D'Ovidio F, Sonett JR, Arcasoy SM, Lederer DJ. Short Stature and Access to Lung Transplantation in the United States. A Cohort Study.  Am J Resp Crit Care Med. 2016; 193(6):681-8. PubMed PMID: 26554631
  19. Cantu E, Suzuki Y, Diamond JM, Ellis J, Tiwari J, Beduhn B, Nellen JR, Shah R, Meyer NJ, Lederer DJ, Kawut SM, Palmer SM, Snyder LD, Hartwig MG, Lama VN, Bhorade S, Crespo M, Demissie E, Wille K, Orens J, Shah PD, Weinacker A, Weill D, Wilkes D, Roe D, Ware LB, Wang F, Feng R, Christie JD. Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk. Am J Transplant. 2016; 16(3):833-40. NIHMSID: NIHMS754709 PubMed PMID: 26663441, PMCID: PMC4767612
  20. Albright K, Walker T, Baird S, Eres L, Farnsworth T, Fier K, Kervitsky D, Korn M, Lederer DJ, McCormick M, Steiner JF, Vierzba T, Wamboldt FS, Swigris JJ. Seeking and sharing: why the pulmonary fibrosis community engages the web 2.0 environment. BMC Pulm Med. 2016; 16:4. PubMed PMID: 26754048, PMCID: PMC4709949
  21. Johnson C, Giles JT, Bathon J, Lederer D, Hoffman EA, Barr RG, Danoff SK. Smoking and Subclinical ILD in RA versus the Multi-Ethnic Study of Atherosclerosis. PloS one. 2016; 11(4):e0153024. PubMed PMID: 27050433, PMCID: PMC4822776
  22. Noble PW, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Lancaster L, Lederer DJ, Leff JA, Nathan SD, Pereira CA, Swigris JJ, Valeyre D, King TE Jr. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials. Eur Resp J. 2016; 47(1):243-53. PubMed PMID: 26647432, PMCID: PMC4697914
  23. Lancaster L, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, King TE Jr, Lederer DJ, Lin Z, Nathan SD, Pereira CA, Swigris JJ, Valeyre D, Noble PW. Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials. BMJ open respiratory research. 2016; 3(1):e000105. PubMed PMID: 26835133, PMCID: PMC4716177
  24. Al-Naamani N, Palevsky HI, Lederer DJ, Horn EM, Mathai SC, Roberts KE, Tracy RP, Hassoun PM, Girgis RE, Shimbo D, Post WS, Kawut SM. Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2016; 13(1):25-30. PubMed PMID: 26501464, PMCID: PMC4722842
  25. *Singer JP, Diamond JM, Gries CJ, McDonnough J, Blanc PD, Shah R, Dean MY, Hersh B, Wolters PJ, Tokman S, Arcasoy SM, Ramphal K, Greenland JR, Smith N, Heffernan P, Shah L, Shrestha P, Golden JA, Blumenthal NP, Huang D, Sonett J, Hays S, Oyster M, Katz PP, Robbins H, Brown M, Leard LE, Kukreja J, Bacchetta M, Bush E, D'Ovidio F, Rushefski M, Raza K, Christie JD, Lederer DJ. Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation.  Am J Resp Crit Care Med. 2015; 192(11):1325-34. PubMed PMID: 26258797, PMCID: PMC4731703
  26. Esposito DB, Lanes S, Donneyong M, Holick CN, Lasky JA, Lederer D, Nathan SD, O'Quinn S, Parker J, Tran TN. Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.  Am J Resp Crit Care Med. 2015; 192(10):1200-7. PubMed PMID: 26241562
  27. Kliment CR, Araki T, Doyle TJ, Gao W, Dupuis J, Latourelle JC, Zazueta OE, Fernandez IE, Nishino M, Okajima Y, Ross JC, Estépar RS, Diaz AA, Lederer DJ, Schwartz DA, Silverman EK, Rosas IO, Washko GR, O'Connor GT, Hatabu H, Hunninghake GM. A comparison of visual and quantitative methods to identify interstitial lung abnormalities. BMC pulmonary medicine. 2015; 15:134. PubMed PMID: 26514822, PMCID: PMC4625729
  28. Shah RJ, Diamond JM, Cantu E, Flesch J, Lee JC, Lederer DJ, Lama VN, Orens J, Weinacker A, Wilkes DS, Roe D, Bhorade S, Wille KM, Ware LB, Palmer SM, Crespo M, Demissie E, Sonnet J, Shah A, Kawut SM, Bellamy SL, Localio AR, Christie JD. Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation. Am J Transplant. 2015; 15(8):2188-96. NIHMSID: NIHMS739515 PubMed PMID: 25877792, PMCID: PMC4721238
  29. Lederer DJ, Bradford WZ, Fagan EA, Glaspole I, Glassberg MK, Glasscock KF, Kardatzke D, King TE Jr, Lancaster LH, Nathan SD, Pereira CA, Sahn SA, Swigris JJ, Noble PW. Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis. Chest. 2015; 148(1):196-201. PubMed PMID: 25856121, PMCID: PMC4493875
  30. *Bernstein EJ, Peterson ER, Sell JL, D'Ovidio F, Arcasoy SM, Bathon JM, Lederer DJ. Survival of adults with systemic sclerosis following lung transplantation: a nationwide cohort study. Arthritis Rheumatol. 2015; 67(5):1314-22. PubMed PMID: 25581250
  31. Matura LA, Ventetuolo CE, Palevsky HI, Lederer DJ, Horn EM, Mathai SC, Pinder D, Archer-Chicko C, Bagiella E, Roberts KE, Tracy RP, Hassoun PM, Girgis RE, Kawut SM. Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertension. Ann Am Thorac Soc. 2015; 12(3):370-5. PubMed PMID: 25615959, PMCID: PMC4418312
  32. Oelsner EC, Hoffman EA, Folsom AR, Carr JJ, Enright PL, Kawut SM, Kronmal R, Lederer D, Lima JA, Lovasi GS, Shea S, Barr RG. Association between emphysema-like lung on cardiac computed tomography and mortality in persons without airflow obstruction: a cohort study. Ann Intern Med. 2014; 161(12):863-73. NIHMSID: NIHMS659435 PubMed PMID: 25506855, PMCID: PMC4347817
  33. *Singer JP, Peterson ER, Snyder ME, Katz PP, Golden JA, D'Ovidio F, Bacchetta M, Sonett JR, Kukreja J, Shah L, Robbins H, Van Horn K, Shah RJ, Diamond JM, Wickersham N, Sun L, Hays S, Arcasoy SM, Palmer SM, Ware LB, Christie JD, Lederer DJ. Body composition and mortality after adult lung transplantation in the United States.  Am J Resp Crit Care Med. 2014; 190(9):1012-21. PubMed PMID: 25233138, PMCID: PMC4299586
  34. Loth DW, Soler Artigas M, Gharib SA, Wain LV, Franceschini N, Koch B, Pottinger TD, Smith AV, Duan Q, Oldmeadow C, Lee MK, Strachan DP, James AL, Huffman JE, Vitart V, Ramasamy A, Wareham NJ, Kaprio J, Wang XQ, Trochet H, Kähönen M, Flexeder C, Albrecht E, Lopez LM, de Jong K, Thyagarajan B, Alves AC, Enroth S, Omenaas E, Joshi PK, Fall T, Viñuela A, Launer LJ, Loehr LR, Fornage M, Li G, Wilk JB, Tang W, Manichaikul A, Lahousse L, Harris TB, North KE, Rudnicka AR, Hui J, Gu X, Lumley T, Wright AF, Hastie ND, Campbell S, Kumar R, Pin I, Scott RA, Pietiläinen KH, Surakka I, Liu Y, Holliday EG, Schulz H, Heinrich J, Davies G, Vonk JM, Wojczynski M, Pouta A, Johansson A, Wild SH, Ingelsson E, Rivadeneira F, Völzke H, Hysi PG, Eiriksdottir G, Morrison AC, Rotter JI, Gao W, Postma DS, White WB, Rich SS, Hofman A, Aspelund T, Couper D, Smith LJ, Psaty BM, Lohman K, Burchard EG, Uitterlinden AG, Garcia M, Joubert BR, McArdle WL, Musk AB, Hansel N, Heckbert SR, Zgaga L, van Meurs JB, Navarro P, Rudan I, Oh YM, Redline S, Jarvis DL, Zhao JH, Rantanen T, O'Connor GT, Ripatti S, Scott RJ, Karrasch S, Grallert H, Gaddis NC, Starr JM, Wijmenga C, Minster RL, Lederer DJ, Pekkanen J, Gyllensten U, Campbell H, Morris AP, Gläser S, Hammond CJ, Burkart KM, Beilby J, Kritchevsky SB, Gudnason V, Hancock DB, Williams OD, Polasek O, Zemunik T, Kolcic I, Petrini MF, Wjst M, Kim WJ, Porteous DJ, Scotland G, Smith BH, Viljanen A, Heliövaara M, Attia JR, Sayers I, Hampel R, Gieger C, Deary IJ, Boezen HM, Newman A, Jarvelin MR, Wilson JF, Lind L, Stricker BH, Teumer A, Spector TD, Melén E, Peters MJ, Lange LA, Barr RG, Bracke KR, Verhamme FM, Sung J, Hiemstra PS, Cassano PA, Sood A, Hayward C, Dupuis J, Hall IP, Brusselle GG, Tobin MD, London SJ. Genome-wide association analysis identifies six new loci associated with forced vital capacity. Nat Genet. 2014; 46(7):669-77. NIHMSID: NIHMS608728 PubMed PMID: 24929828, PMCID: PMC4140093
  35. Shah RJ, Emtiazjoo AM, Diamond JM, Smith PA, Roe DW, Wille KM, Orens JB, Ware LB, Weinacker A, Lama VN, Bhorade SM, Palmer SM, Crespo M, Lederer DJ, Cantu E, Eckert GJ, Christie JD, Wilkes DS. Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation.  Am J Resp Crit Care Med. 2014; 189(12):1564-7. PubMed PMID: 24930532, PMCID: PMC4226014
  36. *Baldwin MR, Reid MC, Westlake AA, Rowe JW, Granieri EC, Wunsch H, Dam TT, Rabinowitz D, Goldstein NE, Maurer MS, Lederer DJ. The feasibility of measuring frailty to predict disability and mortality in older medical intensive care unit survivors. J Crit Care. 2014; 29(3):401-8. NIHMSID: NIHMS569750 PubMed PMID: 24559575, PMCID: PMC4012557
  37. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014; 370(22):2083-92. PubMed PMID: 24836312
  38. Diamond JM, Akimova T, Kazi A, Shah RJ, Cantu E, Feng R, Levine MH, Kawut SM, Meyer NJ, Lee JC, Hancock WW, Aplenc R, Ware LB, Palmer SM, Bhorade S, Lama VN, Weinacker A, Orens J, Wille K, Crespo M, Lederer DJ, Arcasoy S, Demissie E, Christie JD. Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.  Am J Resp Crit Care Med. 2014; 189(5):567-75. PubMed PMID: 24467603, PMCID: PMC3977709
  39. Shah RJ, Wickersham N, Lederer DJ, Palmer SM, Cantu E, Diamond JM, Kawut SM, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Weinacker A, Shah P, Arcasoy S, Wilkes DS, Christie JD, Ware LB. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation. Am J Transplant. 2014; 14(2):446-52. NIHMSID: NIHMS533172 PubMed PMID: 24400993, PMCID: PMC3946770
  40. Lederer DJ, Philip N, Rybak D, Arcasoy SM, Kawut SM. Intravenous immunoglobulin for hypogammaglobulinemia after lung transplantation: a randomized crossover trial. PloS one. 2014; 9(8):e103908. PubMed PMID: 25090414, PMCID: PMC4121238
  41. D'Ovidio F, Kaneda H, Chaparro C, Mura M, Lederer D, Di Angelo S, Takahashi H, Gutierrez C, Hutcheon M, Singer LG, Waddell TK, Floros J, Liu M, Keshavjee S. Pilot study exploring lung allograft surfactant protein A (SP-A) expression in association with lung transplant outcome. Am J Transplant. 2013; 13(10):2722-9. PubMed PMID: 24007361
  42.  *Baldwin MR, Peterson ER, Easthausen I, Quintanilla I, Colago E, Sonett JR, D'Ovidio F, Costa J, Diamond JM, Christie JD, Arcasoy SM, Lederer DJ. Donor age and early graft failure after lung transplantation: a cohort study. Am J Transplant. 2013; 13(10):2685-95. NIHMSID: NIHMS620489 PubMed PMID: 24034167, PMCID: PMC4157369
  43. Baldwin MR, Wunsch H, Reyfman PA, Narain WR, Blinderman CD, Schluger NW, Reid MC, Maurer MS, Goldstein N, Lederer DJ, Bach P. High burden of palliative needs among older intensive care unit survivors transferred to post-acute care facilities. a single-center study. Ann Am Thorac Soc. 2013; 10(5):458-65. PubMed PMID: 23987743, PMCID: PMC3960912
  44. Aramini B, Kim C, Diangelo S, Petersen E, Lederer DJ, Shah L, Robbins H, Floros J, Arcasoy SM, Sonett JR, D'Ovidio F. Donor surfactant protein D (SP-D) polymorphisms are associated with lung transplant outcome. Am J Transplant. 2013; 13(8):2130-6. NIHMSID: NIHMS524442 PubMed PMID: 23841811, PMCID: PMC3819598
  45. Shah RJ, Diamond JM, Cantu E, Lee JC, Lederer DJ, Lama VN, Orens J, Weinacker A, Wilkes DS, Bhorade S, Wille KM, Ware LB, Palmer SM, Crespo M, Localio AR, Demissie E, Kawut SM, Bellamy SL, Christie JD. Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation. Chest. 2013; 144(2):616-22. PubMed PMID: 23429890, PMCID: PMC3734891
  46. Cantu E, Lederer DJ, Meyer K, Milewski K, Suzuki Y, Shah RJ, Diamond JM, Meyer NJ, Tobias JW, Baldwin DA, Van Deerlin VM, Olthoff KM, Shaked A, Christie JD. Gene set enrichment analysis identifies key innate immune pathways in primary graft dysfunction after lung transplantation. Am J Transplant. 2013; 13(7):1898-904. NIHMSID: NIHMS559361 PubMed PMID: 23710539, PMCID: PMC3954988
  47. Kato TS, Cheema FH, Yang J, Kawano Y, Takayama H, Naka Y, Farr M, Lederer DJ, Baldwin MR, Jin Z, Homma S, Mancini DM, Schulze PC. Preoperative serum albumin levels predict 1-year postoperative survival of patients undergoing heart transplantation. Circulation. Heart failure. 2013; 6(4):785-91. NIHMSID: NIHMS589159 PubMed PMID: 23674361, PMCID: PMC4074373
  48. Patel NM, Kawut SM, Jelic S, Arcasoy SM, Lederer DJ, Borczuk AC. Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis. Eur Resp J. 2013; 41(6):1324-30. NIHMSID: NIHMS735053 PubMed PMID: 23728404, PMCID: PMC4720265
  49. Tsuang WM, Vock DM, Finlen Copeland CA, Lederer DJ, Palmer SM. An acute change in lung allocation score and survival after lung transplantation: a cohort study. Ann Intern Med. 2013; 158(9):650-7. NIHMSID: NIHMS501906 PubMed PMID: 23648947, PMCID: PMC3819715
  50. Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Nathan SD, Wells AU, Collard HR, Costabel U, Richeldi L, de Andrade J, Khalil N, Morrison LD, Lederer DJ, Shao L, Li X, Pedersen PS, Montgomery AB, Chien JW, O'Riordan TG. Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann Intern Med. 2013; 158(9):641-9. PubMed PMID: 23648946
  51. Baldwin MR, Narain WR, Wunsch H, Schluger NW, Cooke JT, Maurer MS, Rowe JW, Lederer DJ, Bach PB. A prognostic model for 6-month mortality in elderly survivors of critical illness. Chest. 2013; 143(4):910-9. PubMed PMID: 23632902, PMCID: PMC3616685
  52. Diamond JM, Lee JC, Kawut SM, Shah RJ, Localio AR, Bellamy SL, Lederer DJ, Cantu E, Kohl BA, Lama VN, Bhorade SM, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Shah AS, Weinacker A, Arcasoy S, Shah PD, Wilkes DS, Ware LB, Palmer SM, Christie JD. Clinical risk factors for primary graft dysfunction after lung transplantation.  Am J Resp Crit Care Med. 2013; 187(5):527-34. PubMed PMID: 23306540, PMCID: PMC3733407
  53. Shah RJ, Diamond JM, Lederer DJ, Arcasoy SM, Cantu EM, Demissie EJ, Kawut SM, Kohl B, Lee JC, Sonett J, Christie JD, Ware LB. Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation. Translational research. 2012; 160(6):435-42. NIHMSID: NIHMS404299 PubMed PMID: 22989614, PMCID: PMC3500407
  54. Diamond JM, Meyer NJ, Feng R, Rushefski M, Lederer DJ, Kawut SM, Lee JC, Cantu E, Shah RJ, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Weinacker A, Weill D, Arcasoy S, Shah PD, Belperio JA, Wilkes D, Ware LB, Palmer SM, Christie JD. Variation in PTX3 is associated with primary graft dysfunction after lung transplantation.  Am J Resp Crit Care Med. 2012; 186(6):546-52. PubMed PMID: 22822025, PMCID: PMC3480532
  55. Shah RJ, Bellamy SL, Localio AR, Wickersham N, Diamond JM, Weinacker A, Lama VN, Bhorade S, Belperio JA, Crespo M, Demissie E, Kawut SM, Wille KM, Lederer DJ, Lee JC, Palmer SM, Orens J, Reynolds J, Shah A, Wilkes DS, Ware LB, Christie JD. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation. J Heart Lung Transplant. 2012; 31(9):942-9. NIHMSID: NIHMS386731 PubMed PMID: 22694851, PMCID: PMC3418416
  56. Weingarten JA, Lederer DJ, Ozturk E, Milite FM, Mooney AM, Thomashow BM, Basner RC. A comparison of single breath and re-breathe diffusing capacity in emphysema patients and controls. Respiratory physiology & neurobiology. 2012; 183(1):15-9. PubMed PMID: 22633938
  57. Ventetuolo CE, Lima JA, Barr RG, Bristow MR, Bagiella E, Chahal H, Kizer JR, Lederer DJ, Bluemke DA, Kawut SM. The renin-angiotensin system and right ventricular structure and function: The MESA-Right Ventricle Study. Pulmonary circulation. 2012; 2(3):379-86. PubMed PMID: 23130107, PMCID: PMC3487307
  58. Lederer DJ, Bartels MN, Schluger NW, Brogan F, Jellen P, Thomashow BM, Kawut SM. Sildenafil for chronic obstructive pulmonary disease: a randomized crossover trial. COPD. 2012; 9(3):268-75. NIHMSID: NIHMS779355 PubMed PMID: 22360383, PMCID: PMC4904720
  59. Bastarache JA, Diamond JM, Kawut SM, Lederer DJ, Ware LB, Christie JD. Postoperative estradiol levels associate with development of primary graft dysfunction in lung transplantation patients. Gender Medicine. 2012; 9(3):154-65. NIHMSID: NIHMS361685 PubMed PMID: 22361838, PMCID: PMC3374892
  60. *Baldwin MR, Arcasoy SM, Shah A, Schulze PC, Sze J, Sonett JR, Lederer DJ. Hypoalbuminemia and early mortality after lung transplantation: a cohort study. Am J Transplant. 2012; 12(5):1256-67. NIHMSID: NIHMS451807 PubMed PMID: 22335491, PMCID: PMC3628840
  61. *Hook JL, Arcasoy SM, Zemmel D, Bartels MN, Kawut SM, Lederer DJ. Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis. Eur Resp J. 2012; 39(2):359-65. NIHMSID: NIHMS322520 PubMed PMID: 21885386, PMCID: PMC3236811
  62. Tedford RJ, Hassoun PM, Mathai SC, Girgis RE, Russell SD, Thiemann DR, Cingolani OH, Mudd JO, Borlaug BA, Redfield MM, Lederer DJ, Kass DA. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation. 2012; 125(2):289-97. NIHMSID: NIHMS347197 PubMed PMID: 22131357, PMCID: PMC3264431
  63. *Ventetuolo CE, Kawut SM, Lederer DJ. Plasma endothelin-1 and vascular endothelial growth factor levels and their relationship to hemodynamics in idiopathic pulmonary fibrosis. Respiration. 2012; 84(4):299-305. NIHMSID: NIHMS412309 PubMed PMID: 22869459, PMCID: PMC3495134
  64. Diamond JM, Porteous MK, Cantu E, Meyer NJ, Shah RJ, Lederer DJ, Kawut SM, Lee J, Bellamy SL, Palmer SM, Lama VN, Bhorade SM, Crespo M, Demissie E, Wille K, Orens J, Shah PD, Weinacker A, Weill D, Arcasoy S, Wilkes DS, Ware LB, Christie JD. Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation. PloS one. 2012; 7(12):e51932. PubMed PMID: 23284823, PMCID: PMC3526525
  65. Diamond JM, Lederer DJ, Kawut SM, Lee J, Ahya VN, Bellamy S, Palmer SM, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Shah PD, Weinacker A, Weill D, Kohl BA, Deutschman CC, Arcasoy S, Shah AS, Belperio JA, Wilkes D, Reynolds JM, Ware LB, Christie JD. Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis. Am J Transplant. 2011; 11(11):2517-22. NIHMSID: NIHMS326686 PubMed PMID: 21883907, PMCID: PMC3206646
  66. Lederer DJ, Kawut SM, Wickersham N, Winterbottom C, Bhorade S, Palmer SM, Lee J, Diamond JM, Wille KM, Weinacker A, Lama VN, Crespo M, Orens JB, Sonett JR, Arcasoy SM, Ware LB, Christie JD. Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.  Am J Resp Crit Care Med. 2011; 184(9):1055-61. PubMed PMID: 21799077, PMCID: PMC3208644
  67. *Lamas DJ, Kawut SM, Bagiella E, Philip N, Arcasoy SM, Lederer DJ. Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study.  Am J Resp Crit Care Med. 2011; 184(7):842-7. PubMed PMID: 21719755, PMCID: PMC3208648
  68. Sims MW, Beers MF, Ahya VN, Kawut SM, Sims KD, Lederer DJ, Palmer SM, Wille K, Lama VN, Shah PD, Orens JB, Bhorade S, Crespo M, Weinacker A, Demissie E, Bellamy S, Christie JD, Ware LB. Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis. Chest. 2011; 140(2):489-96. PubMed PMID: 21349925, PMCID: PMC3148793
  69. Kawut SM, Bagiella E, Lederer DJ, Shimbo D, Horn EM, Roberts KE, Hill NS, Barr RG, Rosenzweig EB, Post W, Tracy RP, Palevsky HI, Hassoun PM, Girgis RE. Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT. Circulation. 2011; 123(25):2985-93. NIHMSID: NIHMS297051 PubMed PMID: 21593252, PMCID: PMC3427737
  70. Ginsburg ME, Thomashow BM, Yip CK, DiMango AM, Maxfield RA, Bartels MN, Jellen P, Bulman WA, Lederer D, Brogan FL, Gorenstein LA, Sonett JR. Lung volume reduction surgery using the NETT selection criteria. Ann Thorac Surg. 2011; 91(5):1556-60; discussion 1561. PubMed PMID: 21459360
  71. Fang A, Studer S, Kawut SM, Ahya VN, Lee J, Wille K, Lama V, Ware L, Orens J, Weinacker A, Palmer SM, Crespo M, Lederer DJ, Deutschman CS, Kohl BA, Bellamy S, Demissie E, Christie JD. Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis. Chest. 2011; 139(4):782-7. PubMed PMID: 20864607, PMCID: PMC3071272
  72. Diamond JM, Kawut SM, Lederer DJ, Ahya VN, Kohl B, Sonett J, Palmer SM, Crespo M, Wille K, Lama VN, Shah PD, Orens J, Bhorade S, Weinacker A, Demissie E, Bellamy S, Christie JD, Ware LB. Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction. Am J Transplant. 2011; 11(3):561-7. NIHMSID: NIHMS263252 PubMed PMID: 21299834, PMCID: PMC3079443
  73. Kawut SM, Bagiella E, Shimbo D, Lederer DJ, Al-Naamani N, Roberts KE, Barr RG, Post W, Horn EM, Tracy R, Hassoun P, Girgis R. Rationale and design of a phase II clinical trial of aspirin and simvastatin for the treatment of pulmonary arterial hypertension: ASA-STAT. Contemporary clinical trials. 2011; 32(2):280-7. NIHMSID: NIHMS265000 PubMed PMID: 21146637, PMCID: PMC3034822
  74. Perlman CE, Lederer DJ, Bhattacharya J. Micromechanics of alveolar edema. Am J Respir Cell Mol Biol. 2011; 44(1):34-9. PubMed PMID: 20118224, PMCID: PMC3028256
  75. Christie JD, Bellamy S, Ware LB, Lederer D, Hadjiliadis D, Lee J, Robinson N, Localio AR, Wille K, Lama V, Palmer S, Orens J, Weinacker A, Crespo M, Demissie E, Kimmel SE, Kawut SM. Construct validity of the definition of primary graft dysfunction after lung transplantation. J Heart Lung Transplant. 2010; 29(11):1231-9. NIHMSID: NIHMS212794 PubMed PMID: 20655249, PMCID: PMC2963709
  76. Jelic S, Lederer DJ, Adams T, Padeletti M, Colombo PC, Factor PH, Le Jemtel TH. Vascular inflammation in obesity and sleep apnea. Circulation. 2010; 121(8):1014-21. NIHMSID: NIHMS181051 PubMed PMID: 20159829, PMCID: PMC2864627
  77. Christie JD, Shah CV, Kawut SM, Mangalmurti N, Lederer DJ, Sonett JR, Ahya VN, Palmer SM, Wille K, Lama V, Shah PD, Shah A, Weinacker A, Deutschman CS, Kohl BA, Demissie E, Bellamy S, Ware LB. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.  Am J Resp Crit Care Med. 2009; 180(10):1010-5. PubMed PMID: 19661249, PMCID: PMC2778153
  78. Lederer DJ, Wilt JS, D'Ovidio F, Bacchetta MD, Shah L, Ravichandran S, Lenoir J, Klein B, Sonett JR, Arcasoy SM. Obesity and underweight are associated with an increased risk of death after lung transplantation.  Am J Resp Crit Care Med. 2009; 180(9):887-95. PubMed PMID: 19608717, PMCID: PMC2773915
  79. Lederer DJ, Enright PL, Kawut SM, Hoffman EA, Hunninghake G, van Beek EJ, Austin JH, Jiang R, Lovasi GS, Barr RG. Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study.  Am J Resp Crit Care Med. 2009; 180(5):407-14. PubMed PMID: 19542480, PMCID: PMC2742759
  80. Kawut SM, Okun J, Shimbo D, Lederer DJ, De Andrade J, Lama V, Shah A, Milstone A, Ware LB, Weinacker A, Demissie E, Christie JD. Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation. Chest. 2009; 136(1):237-44. PubMed PMID: 19255296, PMCID: PMC2821286
  81. Celik MR, Lederer DJ, Wilt J, Eser D, Bacchetta M, D'Ovidio F, Sonett JR, Arcasoy SM. Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study. J Heart Lung Transplant. 2009; 28(7):697-703. PubMed PMID: 19560698
  82. Lederer DJ, Jelic S, Basner RC, Ishizaka A, Bhattacharya J. Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea. Eur Resp J. 2009; 33(4):793-6. NIHMSID: NIHMS120825 PubMed PMID: 19336590, PMCID: PMC2739049
  83. Zisman DA, Kawut SM, Lederer DJ, Belperio JA, Lynch JP 3rd, Schwarz MI, Tayek JA, Reuben DB, Karlamangla AS. Serum albumin concentration and waiting list mortality in idiopathic interstitial pneumonia. Chest. 2009; 135(4):929-35. NIHMSID: NIHMS84192 PubMed PMID: 19017875, PMCID: PMC2666778
  84. Milite F, Lederer DJ, Weingarten JA, Fani P, Mooney AM, Basner RC. Quantification of single-breath underestimation of lung volume in emphysema. Respiratory physiology & neurobiology. 2009; 165(2-3):215-20. NIHMSID: NIHMS120828 PubMed PMID: 19150417, PMCID: PMC2759678
  85. Jelic S, Lederer DJ, Adams T, Padeletti M, Colombo PC, Factor P, Le Jemtel TH. Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea. Vascular health and risk management. 2009; 5:909-20. PubMed PMID: 19997572, PMCID: PMC2788596
  86. Al-Naamani N, Maarouf OH, Wilt JS, Bacchetta M, D'Ovidio F, Sonett JR, Arcasoy SM, Lederer DJ, Nickolas TL, Kawut SM. The modification of diet in renal disease (MDRD) and the prediction of kidney outcomes after lung transplantation. J Heart Lung Transplant. 2008; 27(11):1191-7. PubMed PMID: 18971090
  87. Yiming MT, Lederer DJ, Sun L, Huertas A, Issekutz AC, Bhattacharya S. Platelets enhance endothelial adhesiveness in high tidal volume ventilation. Am J Respir Cell Mol Biol. 2008; 39(5):569-75. PubMed PMID: 18483418, PMCID: PMC2574527
  88. Al-Naamani N, Maarouf OH, Ahya VN, Lederer DJ, Mendez JD, Wilt JS, Doyle AM, Rybak D, D'Ovidio F, Sonett JR, Arcasoy SM, Nickolas TL, Kawut SM. Assessment of kidney function in lung transplant candidates. J Heart Lung Transplant. 2008; 27(6):635-41. PubMed PMID: 18503963
  89. Brodie D, Lederer DJ, Gallardo JS, Trivedi SH, Burzynski JN, Schluger NW. Use of an interferon-gamma release assay to diagnose latent tuberculosis infection in foreign-born patients. Chest. 2008; 133(4):869-74. PubMed PMID: 18198254
  90. Sternberg DI, Shimbo D, Kawut SM, Sarkar J, Hurlitz G, D'Ovidio F, Lederer DJ, Wilt JS, Arcasoy SM, Pinsky DJ, D'Armiento JM, Sonett JR. Platelet activation in the postoperative period after lung transplantation. J Thorac Cardiovasc Surg. 2008; 135(3):679-84. NIHMSID: NIHMS173607 PubMed PMID: 18329493, PMCID: PMC2829430
  91. Lederer DJ, Benn EK, Barr RG, Wilt JS, Reilly G, Sonett JR, Arcasoy SM, Kawut SM. Racial differences in waiting list outcomes in chronic obstructive pulmonary disease.  Am J Resp Crit Care Med. 2008; 177(4):450-4. PubMed PMID: 18006881, PMCID: PMC2258441
  92. Kawut SM, Lederer DJ, Keshavjee S, Wilt JS, Daly T, D'Ovidio F, Sonett JR, Arcasoy SM, Barr ML. Outcomes after lung retransplantation in the modern era.  Am J Resp Crit Care Med. 2008; 177(1):114-20. PubMed PMID: 17901410
  93. Lederer DJ, Horn EM, Rosenzweig EB, Karmally W, Jahnes M, Barst RJ, Kawut SM. Plasma serotonin levels are normal in pulmonary arterial hypertension. Pulmonary pharmacology & therapeutics. 2008; 21(1):112-4. NIHMSID: NIHMS39426 PubMed PMID: 17374499, PMCID: PMC2267916
  94. Lederer DJ, Arcasoy SM. Update in surgical therapy for chronic obstructive pulmonary disease. Clinics in chest medicine. 2007; 28(3):639-53, vii. PubMed PMID: 17720050
  95. Yegen HA, Lederer DJ, Barr RG, Wilt JS, Fang Y, Bagiella E, D'Ovidio F, Okun JM, Sonett JR, Arcasoy SM, Kawut SM. Risk factors for venous thromboembolism after lung transplantation. Chest. 2007; 132(2):547-53. PubMed PMID: 17573512
  96. Lederer DJ, Thomashow BM, Ginsburg ME, Austin JH, Bartels MN, Yip CK, Jellen PA, Brogan FL, Kawut SM, Maxfield RA, DiMango AM, Simonelli PF, Gorenstein LA, Pearson GD, Sonett JR. Lung-volume reduction surgery for pulmonary emphysema: Improvement in body mass index, airflow obstruction, dyspnea, and exercise capacity index after 1 year. J Thorac Cardiovasc Surg. 2007; 133(6):1434-8. PubMed PMID: 17532935
  97. Lederer DJ, Arcasoy SM, Barr RG, Wilt JS, Bagiella E, D'Ovidio F, Sonett JR, Kawut SM. Racial and ethnic disparities in idiopathic pulmonary fibrosis: A UNOS/OPTN database analysis. Am J Transplant. 2006; 6(10):2436-42. NIHMSID: NIHMS620371 PubMed PMID: 16869805, PMCID: PMC4153708
  98. Lederer DJ, Arcasoy SM, Wilt JS, D'Ovidio F, Sonett JR, Kawut SM. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis.  Am J Resp Crit Care Med. 2006; 174(6):659-64. PubMed PMID: 16778159, PMCID: PMC2648057
  99. Yip NH, Lederer DJ, Kawut SM, Wilt JS, D'Ovidio F, Wang Y, Dwyer E, Sonett JR, Arcasoy SM. Immunoglobulin G levels before and after lung transplantation.  Am J Resp Crit Care Med. 2006; 173(8):917-21. PubMed PMID: 16399990, PMCID: PMC2662910
  100. Lederer DJ, Caplan-Shaw CE, O'Shea MK, Wilt JS, Basner RC, Bartels MN, Sonett JR, Arcasoy SM, Kawut SM. Racial and ethnic disparities in survival in lung transplant candidates with idiopathic pulmonary fibrosis. Am J Transplant. 2006; 6(2):398-403. PubMed PMID: 16426327
  101. Caplan-Shaw CE, Arcasoy SM, Shane E, Lederer DJ, Wilt JS, O'Shea MK, Addesso V, Sonett JR, Kawut SM. Osteoporosis in diffuse parenchymal lung disease. Chest. 2006; 129(1):140-6. PubMed PMID: 16424424
  102. Kawut SM, Horn EM, Berekashvili KK, Lederer DJ, Widlitz AC, Rosenzweig EB, Barst RJ. Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension. Pulmonary pharmacology & therapeutics. 2006; 19(5):370-4. PubMed PMID: 16483811
  103. Kawut SM, Reyentovich A, Wilt JS, Anzeck R, Lederer DJ, O'Shea MK, Sonett JR, Arcasoy SM. Outcomes of extended donor lung recipients after lung transplantation. Transplantation. 2005; 79(3):310-6. PubMed PMID: 15699761
  104. Batuman O, Go D, Clark LT, Smith EL, Clements P, Feit A, Lederer D. Relationship between cytokine levels and coronary artery disease in women. Heart disease 2001; 3(2):80-4. PubMed PMID: 11975775

B. Case Reports

  1. Lederer DJ, Kawut SM, Sonett JR, Vakiani E, Seward SL Jr, White JG, Wilt JS, Marboe CC, Gahl WA, Arcasoy SM. Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome. J Heart Lung Transplant. 2005; 24(10):1697-9. PubMed PMID: 16210149

C. Books and Chapters

  1. *Lamas DJ, Lederer DJ. Book Chapter: Lung Transplantation for Idiopathic Pulmonary Fibrosis. In: Meyer K & Nathan S, Eds. Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical Guide, 2nd edition. Humana Press, Springer, (in press)
  2. *Lamas DJ, Lederer DJ. Book Chapter: Lung Transplantation for Idiopathic Pulmonary Fibrosis. In: Meyer K & Nathan S, Eds. Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical Guide, 1st edition. Humana Press, Springer, 2014.

D. Reviews and editorials

Reviews

  1. Lederer DJ, Martinez FJ. Idiopathic Pulmonary Fibrosis. N Engl J Med 2018;378(19):1811-1823. PMID: 29742380
  2. Singer JP, Lederer DJ, Baldwin MR. Frailty in Pulmonary and Critical Care Medicine. Ann Am Thorac Soc. 2016; 13(8):1394-404. PubMed PMID: 27104873, PMCID: PMC5021078
  3. Norfolk SG, Lederer DJ, Tapson VF. Lung transplantation and atrial septostomy in pulmonary arterial hypertension. Clinics in chest medicine. 2013; 34(4):857-65. PubMed PMID: 24267309
  4. *Hook JL, Lederer DJ. Selecting lung transplant candidates: where do current guidelines fall short? Expert review of respiratory medicine. 2012; 6(1):51-61. NIHMSID: NIHMS357121 PubMed PMID: 22283579, PMCID: PMC3286653
  5. Patel NM, Lederer DJ, Borczuk AC, Kawut SM. Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest. 2007; 132(3):998-1006. PubMed PMID: 17873194
  6. Lederer DJ, Arcasoy SM. Update in surgical therapy for COPD. Clin Chest Med 2007; 28(3);639-53. PMID: 17720050
     

Editorials

  1. Lederer DJ. AnnalsATS 2022: Rigor, Value Impact. Ann Am Thorac Soc 2017; 4(12):1753-1754.
  2. * Podolanczuk AJ, Lederer DJ. Patient-Centered Outcomes in Idiopathic Pulmonary Fibrosis Clinical Trials. Am J Respir Crit Care Med. 2017; 196(6):674-675. doi: 10.1164/rccm.201705-0975ED. PMID: 28609111
  3. * Homer R, Lederer DJ. Diagnosing idiopathic pulmonary fibrosis without a lung biopsy: honeycombing not required. Thorax. 2017;72(5):391-392. doi: 10.1136/thoraxjnl-2016-209831. Epub 2017 Mar 9. PMID: 28280234
  4. Lederer DJ, Swigris JJ. Idiopathic Pulmonary Fibrosis on the Internet. Let's Calm the Sea of (Mis)information.  Am J Resp Crit Care Med. 2016; 194(2):134-6. PubMed PMID: 27420357
  5. *Lindell KO, Lederer DJ. Living with Interstitial Lung Disease: How Do We Best Meet the Educational Needs of Our Patients? Ann Am Thorac Soc. 2016; 13(7):1001-2. PubMed PMID: 27388397
  6. *Patel NM, Borczuk AC, Lederer DJ. Cryobiopsy in the Diagnosis of Interstitial Lung Disease. A Step Forward or Back?  Am J Resp Crit Care Med. 2016; 193(7):707-9. PubMed PMID: 27035778
  7. Lederer DJ, Hansen-Flaschen J. Editors' Introduction to AnnalsATS Clinical Research Design Articles. Ann Am Thorac Soc. 2015; 12(10):1436-7. PubMed PMID: 26448350
  8. Lederer DJ. Embracing complex diseases. The case for an idiopathic pulmonary fibrosis biorepository. Ann Am Thorac Soc. 2014; 11(8):1248-9. PubMed PMID: 25343192
  9. Lederer DJ. Clinical trials in idiopathic pulmonary fibrosis: a framework for moving forward. Eur Resp J. 2013; 42(6):1446-8. PubMed PMID: 24293416
  10. *Yusen RD, Lederer DJ. Disparities in lung transplantation. J Heart Lung Transplant. 2013; 32(7):673-4. PubMed PMID: 23796151
  11. *Hook JL, Lederer DJ. Socioeconomic barriers to lung transplantation: balancing access and equity.  Am J Resp Crit Care Med. 2012; 186(10):937-9. PubMed PMID: 23155209
  12. Lederer DJ. Secondary prevention of idiopathic pulmonary fibrosis: catching the horse still in the barn.  Am J Resp Crit Care Med. 2012; 185(7):697-9. PubMed PMID: 22467803
  13. Lederer DJ. Translational research in lung transplantation: how do we get from mouse to human? Am J Transplant. 2012; 12(2):281-2. PubMed PMID: 22151966
  14. Lederer DJ, Arcasoy SM. Two, one, or none for chronic obstructive pulmonary disease: who decides and how?  Am J Resp Crit Care Med. 2011; 184(11):1226-7. PubMed PMID: 22162883
     

Workshops and Guidelines

  1. Ryerson CJ, Corte TJ, Lee JS, Richeldi L, Walsh SLF, Myers JL, Behr J, Cottin V, Danoff SK, Flaherty KR, Lederer DJ, Lynch DA, Martinez FJ, Raghu G, Travis WD, Udwadia Z, Wells AU, Collard HR. A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease: An International Working Group Perspective. Am J Respir Crit Care Med. 2017; 196(10):1249-1254. doi: 10.1164/rccm.201702-0400PP. PMID: 28414524
  2. Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, Lee JS, Maher TM, Wells AU, Antoniou KM, Behr J, Brown KK, Cottin V, Flaherty KR, Fukuoka J, Hansell DM, Johkoh T, Kaminski N, Kim DS, Kolb M, Lynch DA, Myers JL, Raghu G, Richeldi L, Taniguchi H, Martinez FJ. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.  Am J Resp Crit Care Med. 2016; 194(3):265-75. PubMed PMID: 27299520
  3. Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S, Lederer DJ, Mulligan MJ, Patterson GA, Singer LG, Snell GI, Verleden GM, Zamora MR, Glanville AR. A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2015; 34(1):1-15. PubMed PMID: 25085497
  4. Rosas IO, Dellaripa PF, Lederer DJ, Khanna D, Young LR, Martinez FJ. Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc. 2014; 11 Suppl 3:S169-77. PubMed PMID: 24754826, PMCID: PMC4112506

Letters

  1. Lederer DJ, Sell J. Reply: Disparities in Access to Lung Transplantation-More Than Meets the Eye.  Am J Resp Crit Care Med. 2016; 194(5):643-4. PubMed PMID: 27585388
  2. Lederer DJ, Jelic S, Bhattacharya J, Basner RC. Is obstructive sleep apnea a cause of idiopathic pulmonary fibrosis? Archives of pathology & laboratory medicine. 2012; 136(5):470; author reply 470. PubMed PMID: 22540293